Antiphospholipid antibody-mediated foetal loss: identifying mechanisms and developing new treatments

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Certain immune diseases (Lupus, Anti-phospholipid syndrome) are associated with foetal loss. It is thought to be due to inflammation and blood clotting on the blood vessel lining (endothelium). This proposal will study the mechanisms that stimulate inflammation and blood clotting, and also devise new treatments.

Funded Activity Details

Start Date: 01-01-2009

End Date: 01-01-2011

Funding Scheme: NHMRC Project Grants

Funding Amount: $547,970.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Public health nutrition

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

antiphospholipid antibodies | complement activation | fetal loss | inflammation | lupus | miscarriages | thrombosis | tissue factor